The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
Colorectal cancer (CRC) is the third most common cancer in China, however, publicly available, descriptive information on the clinical epidemiology of CRC is limited.
Methods
Patients diagnosed with primary CRC during 2005 through 2014 were sampled from 13 tertiary hospitals in 9 provinces across China. Data related to sociodemographic characteristics, the use of diagnostic technology,...
BACKGROUNDTo assess the association between single nucleotide polymorphisms (SNPs) of base‐excision repair genes and clinical outcomes, the roles of genetic variants of 3 selected genes—flap structure‐specific endonuclease 1 (FEN1), 8‐hydroxyguanine DNA glycosylase (hOGG1), and nei endonuclease VIII‐like 1 (NEIL1)—were investigated in radiation‐induced esophageal toxicity (RIET), radiation pneumonitis...
BACKGROUNDThe objective of this study was to evaluate and identify patterns of failure and prognostic factors for locoregional recurrence (LRR) that could justify postmastectomy radiotherapy after modified radical mastectomy in patients with early stage triple‐negative breast cancer.
METHODSBetween January 2000 and July 2007, the authors retrospectively analyzed 390 patients who had triple‐negative...
BACKGROUND:When epithelial ovarian cancer is detected at an early stage (I‐II), the 5‐year survival rate is between 70% and 90%; whereas, when it is detected in late stages (III‐IV), the 5‐year survival rate slips to <30%. In a previous report, the authors observed that proteomic biomarkers and cancer antigen 125 (CA 125) exhibited a sensitivity of 84% at a specificity of 98% for identifying sera...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.